Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

EastWest Bioscience Inc V.EAST.H

EastWest Bioscience Inc. is a Canada-based vertically integrated wellness company with a multitude of business units and assets that allow for seed-to-sale supply chain management. The Company sources its raw materials, processes, manufactures, tests, brands, markets, and distributes its products to its customers in Canada, the United States and others. It owns and operates retail and manufacturing subsidiaries. Its retail subsidiary (natural health retail franchise - the Sangster's health centers) is engaged in the health and wellness industry. Its stores provide natural remedies for the prevention and treatment of disease and ailments. It has over 202 exclusively labeled products, including vitamins, mineral, herbs, proteins, natural body care and organic foods. The Company, through its subsidiary, Orchard Vale Naturals Inc., is a Health Canada licensed manufacturing facility with capabilities to encapsulate, package and label. It manufactures health supplements for B2B clients.


TSXV:EAST.H - Post by User

Post by Riskitbiscuiton Oct 22, 2019 5:09pm
119 Views
Post# 30256419

My Thoughts On Where The Stock Is At

My Thoughts On Where The Stock Is At

I posted this earlier on CEO.ca, but for anyone who is interested: 

"I would love an update on J.V. with Benchmark. I don’t know what’s stalling it. I do know that the company is focusing heavily on U.S. operations, which is a smart move, given the size of the market and the fact they already have CBD products in production there. Let me be frank, it’s no secret the company is low on cash, and another PP would be daunting in this sector given its bearishness the past year. If I had to make an educated guess, given the facts of where the company is in its development and what assets/cash they have on hand, and where the market is at, I would bet money they are cutting back on unnecessary costs and focusing their attention on getting to profitability ASAP before they run out of cash. That means cutting costs, running a skeleton crew, stalling agreements that would require significant investment from both parties. U.S. operations are the fastest way to reach profitability at the moment, and if I was Rodney I would be focusing on getting those operations running at maximum capacity. If that’s what is going on here, and I’m betting money it is, it makes sense that everything else is on the back burner. Stock price aside, I like the approach management is taking here. They are making the correct decision in focusing south of the border given the situation they are in. And a big part of that is the bearishness of the sector right now. East stock price has been punished way more than it deserves."

I am still buying down here at 3 cents. Looking forward to, and cautiously optimistic about next quarterly financials. Look to see growth in revenues from U.S. operations, and continued growth from Sangsters franchise here in Canada.

 

 

<< Previous
Bullboard Posts
Next >>